肿瘤学:临床前,临床yaboapp体育官网试验和市场后

More than half a million people with cancer will die this year; our mission is to help you improve people's health and lives. From hundreds of preclinical药理学肿瘤模型细胞系测定to running肿瘤学临床试验与市场后研究在数十个国家的数千名患者中,我们可以帮助您获得下一个突破性癌症药物精密药物治疗to those who desperately need it.

Oncology has become the most research-intensive therapeutic area in drug development. You need a patient-centric CRO partner who can be wth you every step of the journey.

  • 拥抱一个针对特定患者疗法的个性化药物方法,并在药物发育的临床前阶段开始yaboapp体育官网
  • 利用生物标志物在临床肿瘤学发展中,为早期决策以及患者和网站选择提供关键数据
  • 共同开发药物肿瘤学伴随诊断识别为了帮助识别最有可能从您的下一次癌症突破中受益的患者
Webinar Series: Precision Medicine Applications in Oncology

临床试验

  • 在过去的五年中,考虑到了Covance的专业知识,见解和市场影响975 oncology studies(300例免疫肿瘤学)在83个国家的近19,000个地点,肿瘤学患者超过104,000名。

  • Data-driven and biomarker selection for patient recruitment

肿瘤学诊断

Featured screening & diagnostic tests:

  • OmniSeq
  • IntelliGEN® Myeloid
  • PD-L1 Testing

yaboapp体育官网临床前免疫疗法

该行业已接近免疫肿瘤学from many angles, thus requiring identification, development and refinement of models capable of recapitulating optimal biological dynamics along with the associated and relevant endpoints.

精密药物和临床试验

Making gains in临床试验的精密药物需要新颖的方法来快速测试和靶向合适的个体。除了几十个后期免疫肿瘤临床试验, we have also supported more than 70% of allFDA-approved companion diagnostic products.

Woman kissing forehead of her friend

肿瘤学教育资源

我们期待着在很多人与您见面肿瘤学和免疫学事件this year.